Stock Club

We normally talk about the characteristics we love to find in stocks. But this week, we bring you all the things we hate. We’ve all gotten caught in a hype cycle or seen an investment thesis degrade, so having a list of red flags to look for is a great way to check in with your portfolio.
They include:
Over-promising. It can be hard to spot fraud in the early days, but if a company is hyperbolic in its language, give it some time. Pre-revenue companies are especially prone to talking big, and they’re a hard pass for Mike.
Management woes. Referencing Good to Great by Jim Collins, Emmet reminds us a great CEO is someone with fierce resolve and a degree of humility. The inverse can be very damaging and often looks like prioritizing short-term gains and selling significant stock during all-time highs. A revolving door of CEOs is also a huge red flag.
Creative accounting. If you see a big difference between net profit and cash flows, or an overuse of adjusted EBITDA, you might want to think twice. These can indicate profits are tied up in unpaid bills or outsized stock-based compensation, which dilutes investors over time.
Deteriorating fundamentals. Slowing revenue growth, compressed margins, bland return on equity (ROE), or rising customer acquisition costs can all signal a business entering decline. However, if you think you’ve spotted a potential turnaround play, these may also be present.
Unforeseen circumstances. Significant, world-changing disruption is also hard to predict, which is why diversification is key. SaaS businesses being upended by AI is a good example.
Valuation. You can buy great businesses, but at extreme prices they can be bad investments. Don’t completely avoid stocks at 25x earnings, as a company can keep delivering, but stay within the realms of reality.
Customer concentration. Reliance on a single client can be a huge risk. It’s particularly prevalent among small businesses that serve enterprises. Progyny (PGNY) vs Amazon (AMZN) is a good case study.
High dividend yield. Yields of 8–10% are often too high. If the payout ratio is above 100%, the company may be borrowing money to pay investors. That won’t last long.
Binary outcomes. For example, pharmaceutical companies waiting for regulatory approval. If they fail, the business can collapse.
After all that, Emmet brings us Follow Prophet, talking about its recent addition, SPX Technologies (SPXC).
Finally, we celebrate Ireland’s new investing accounts. Simon Harris has announced that we will follow the Swedish model, with a launch expected in 2027. We’ll break down the full announcement next week.
Our Horizon portfolio is a boutique service led by our co-founder and lead investor, Emmet Savage. According to 100-bagger expert Chris Mayer, “no one owns more 100-baggers than Emmet”.
This week, he’s adding a new stock that has passed 3 AI screeners and got a shout out from Porter Stansbury. Lucky for Stock Club listeners, they can claim as exclusive offer by emailing: [email protected].
Psssst…. We don’t think you’ll want to miss this year’s Investicon. Grab your early bird tickets now: https://www.investicon.ie/
Become a successful investor by checking out all the content MyWallSt has to offer:
📩 Email us: [email protected]
📚 Learn the fundamentals of investing by downloading our free Learn app: https://bit.ly/3DXPOz7
💻 Keep updated on stock market news by visiting our blog: https://mywallst.com/blog/
🎧 Tune in to our podcast Stock Club to stay updated on weekly news: https://mywallst.com/stock-investment-podcast/
🎉 Follow MyWallSt on social:
❌ X: @MyWallStHQ
💃 TikTok: @MyWallSt
📸 Instagram: @MyWallSt
🖥️ Facebook: @MyWallSt
👔 LinkedIn: MyWallSt
(adjust these after intro)
00:00 Intro04:31 Shorting Stocks Talk10:35 Founder CEOs vs Insider Selling17:35 Creative Accounting22:35 Deteriorating Fundamentals30:59 Valuation Reality Check32:27 Customer Concentration34:20 High Dividend Yield37:25 Following Prophet43:24 Ireland’s New Investment Scheme

Investor Down Under — g’day. We’ve long loved hunting for underappreciated stocks abroad, and over the years we’ve realized Australia is a particularly great place to find them. With its investing culture on the rise, this week we’re highlighting some of our local favorites.
Emmet brings you a “high-quality moonshot with revenue.” Out of character for him, it’s Telix Pharmaceuticals (ASX: TLX). He normally avoids pharma and fashion, mostly because it rhymes. Telix develops and sells radiopharmaceuticals, including diagnostic tools (“theranostics”), primarily in oncology.
Its annualized revenue growth is a thing of beauty. It went from generating $4 million in revenue in 2020 to $800 million in 2025. That growth is driven entirely by its diagnostic technology, not treatment, which is still in development. This makes it a potentially less risky cancer-curing play.
If you’re a fan of Aussie stocks and want to hear Mike’s all-time favorite, you’ll need a Nexus 3 subscription. But his second favorite is Supply Network Limited (SNL), a provider of bus and truck parts. It’s a classic Mike, and Peter Lynch, type of play.
Its moat lies in its depth of inventory and expertise in parts interpreting. It also has strong local market knowledge. Trucking is huge in Australia, but fleets are aging and often consist of vehicles from dozens of manufacturers, many concentrated in different parts of the country. Knowing what parts will be needed and where is a major advantage. The company has also grown revenue at a 17% CAGR over the past decade.
Modernization could pose a threat through automation or electrification, but it’s unlikely to play out meaningfully over the next decade.
We wrap up with Mike and Emmet sharing how they would invest $10K across these stocks.
If you’re a new investor looking to start off on the right foot, we think Stock of the Month is the service for you. Every month, we pitch you one accessible, long-term stock we love, with a comprehensive write-up. We’ve been lucky to have some big winners, like Shopify which has returned more than 2600% since we picked it in 2017.
Head to https://www.mywallst.com/stock-of-the-month to get all the details.
Psssst…. We don’t think you’ll want to miss this year’s Investicon. Grab your early bird tickets now: https://www.investicon.ie/
Become a successful investor by checking out all the content MyWallSt has to offer:
📩 Email us: [email protected]
📚 Learn the fundamentals of investing by downloading our free Learn app: https://bit.ly/3DXPOz7
💻 Keep updated on stock market news by visiting our blog: https://mywallst.com/blog/
🎧 Tune in to our podcast Stock Club to stay updated on weekly news: https://mywallst.com/stock-investment-podcast/
🎉 Follow MyWallSt on social:
❌ X: @MyWallStHQ
💃 TikTok: @MyWallSt
📸 Instagram: @MyWallSt
🖥️ Facebook: @MyWallSt
👔 LinkedIn: MyWallSt
00:00 Intro01:40 Kalashi and predictive markets rant
06:41 Why Focus on Australia14:39 Telex Pharmaceuticals 18:32 Why Telex Excites Investors20:44 Moat and Market Expansion21:52 Risks26:30 Supply Network Limited (ASX: SNL)28:40 Moat Through Parts Expertise and Market Outlook37:57 10K Split and Wrap Up

This week, Emmet and Mike are digging into one of the hottest trends of our futuristic world: human longevity. We’ve all seen Bryan Johnson on our social feeds, but the business of living longer is more than just a meme. Today, new-age pharmaceutical companies are leveraging AI to reinvent the drug development process—making it faster, cheaper, and more customizable. If they’re successful, it could become one of the most important scientific innovations of all time.
This raises the question: how do you invest in it?
Emmet sees four categories:
Metabolic longevity — Eli Lilly, Novo Nordisk
Early disease detection — Guardant Health, Exact Sciences
Longevity infrastructure — Thermo Fisher, Danaher Corp
Moonshots — Recursion Pharmaceuticals Inc
But which stocks are the lads’ favorites?
Mike favors Tempus AI (TEM) for its two-pronged business model, composed of diagnostics and data. The diagnostics side is similar to Guardant Health, focusing on hereditary and sequencing tests. The data side consists of vast libraries of medical data that are licensed to other pharma and biotech companies, enabling things like trial design, pre-validation, and patient enrollment. They also have some impressive stats: net revenue retention sits at 126%, and they have over a billion dollars in backlog.
Emmet goes with a stock he previously added to his watchlist, but later removed due to its complexity: Recursion Pharmaceuticals. It has a validated, full-stack platform for AI-driven drug discovery, but currently licenses data from Tempus AI. It recently achieved its first patented result from its AI system, which is considered a major breakthrough.
They wrap up by sharing which stock they would invest in today.

In celebration of St. Patrick’s Day, all of our services are on sale. From Horizon to Prophet, it’s a great time to find your next life-changing investment (at a discount). Importantly, our Insider Bot lives inside Horizon so if you want to invest like a CEO or CFO now is the time.
To lock in your special rate, email [email protected]
Psssst…. We don’t think you’ll want to miss this year’s Investicon. Grab your early bird tickets now: https://www.investicon.ie/
Become a successful investor by checking out all the content MyWallSt has to offer:
📩 Email us: [email protected]
📚 Learn the fundamentals of investing by downloading our free Learn app: https://bit.ly/3DXPOz7
💻 Keep updated on stock market news by visiting our blog: https://mywallst.com/blog/
🎧 Tune in to our podcast Stock Club to stay updated on weekly news: https://mywallst.com/stock-investment-podcast/
🎉 Follow MyWallSt on social:
❌ X: @MyWallStHQ
💃 TikTok: @MyWallSt
📸 Instagram: @MyWallSt
🖥️ Facebook: @MyWallSt
👔 LinkedIn: MyWallSt
00:00 Intro01:31 Why Longevity Matters07:31 Demis Hassabis on the Future of AI15:08 Longevity Investing Archetypes24:16 Tempus AI Overview31:39 Recursion Pharma Pitch45:07 10K Portfolio Split

We’ve pitched you businesses and described graphs, but this week Mike and Emmet put the power in your hands and teach you how to find multibagger stocks. And it can be as simple as one metric: insider ownership.
Inspired by the beloved book Investment Intelligence, we show you how to monitor and understand insider buying. This includes which executives to pay special attention to, how much is considered a meaningful purchase, and how to distinguish between virtue signalling and genuine investment.
Overall, insiders are great at identifying when stocks are undervalued, especially when that undervaluation is driven by poor market sentiment. They might not be the best at timing the absolute bottom (to be fair, who is?), but they often reap the rewards over the long term.
Emmet also reveals that the insider signal with the greatest historical returns is when a CEO buys shares after a large decline. If they’re willing to stake both their reputation and cold hard cash on better days ahead, it’s worth paying attention.
It’s also an apt time for the topic, as there has been a flurry of insider buying recently, so Mike walks you through some of the biggest headlines.
Anthony Noto, CEO of SoFi Technologies (SOFI), bought roughly $1 million worth of shares on March 2nd, almost calling the bottom to the cent.
Scott Nuttall and Joseph Bae, Co-CEOs of KKR & Co. (KKR), also stepped in to buy shares despite growing concerns about the private credit market. With the stock down roughly 40% since July, the pair each purchased 100,000 shares across two rounds of buying. The cluster buying suggests leadership sees an opportunity.
Greg Abel, Vice Chairman of Berkshire Hathaway (BRK.A, BRK.B) and Warren Buffett’s designated successor, has committed his $15 million salary to buying Berkshire shares. This appears to be as much a cultural signal as an investment decision, reinforcing Berkshire’s long-standing emphasis on alignment between management and shareholders.
Jeff Green, CEO of The Trade Desk (TTD), bought nearly $150 million in shares at the beginning of the month. The stock has fallen significantly from its highs amid concerns that Amazon (AMZN) is building its own competing advertising platform. However, news broke on March 5th that The Trade Desk may partner with OpenAI on advertising opportunities and the stock soared. But everyone thinks the timing is a little suspicious.
Andrew Robinson, CEO of Skyward Specialty Insurance (SKWD), has also been buying shares. The company recently caught Emmet’s eye so he was excited to see the disclosure.
We wrap with Follow Prophet.
In celebration of St. Patrick’s Day, all of our services are on sale. From Horizon to Prophet, it’s a great time to find your next life-changing investment (at a discount). Importantly, our Insider Bot lives inside Horizon so if you want to invest like a CEO or CFO now is the time.
To lock in your special rate, email [email protected]
Psssst…. We don’t think you’ll want to miss this year’s Investicon. Grab your early bird tickets now: https://www.investicon.ie/
Become a successful investor by checking out all the content MyWallSt has to offer:
📩 Email us: [email protected]
📚 Learn the fundamentals of investing by downloading our free Learn app: https://bit.ly/3DXPOz7
💻 Keep updated on stock market news by visiting our blog: https://mywallst.com/blog/
🎧 Tune in to our podcast Stock Club to stay updated on weekly news: https://mywallst.com/stock-investment-podcast/
🎉 Follow MyWallSt on social:
❌ X: @MyWallStHQ
💃 TikTok: @MyWallSt
📸 Instagram: @MyWallSt
🖥️ Facebook: @MyWallSt
👔 LinkedIn: MyWallSt
00:00 Intro05:23 Why Insider Buying Matters17:09 Cluster Buys And Timing20:21 Insider Bot Alerts Explained22:10 SoFi Buys26:56 ServiceNow CEO Buys29:17 Trade Desk Mega Buy36:45 CFO Buys Matter41:18 Follow Prophet

This week, we’re heading to safer shores — trading moonshots for mailboxes — and bringing you Emmet and Mike’s favorite dividend stocks.
We’re growth investors at heart and would usually rather see smart R&D spending than dividend distributions. But for many investors, especially those approaching retirement, a few value stocks can be a smart addition to a portfolio.
Emmet walks us through why a company might start offering a dividend — and why it might not. The decision can come down to a mix of cash availability, tax laws, pressure from large shareholders, and a desire to stay in the market’s good graces over the long term.
He kicks things off with the Dividend Aristocrats (NOBL) ETF, an index of US companies that have increased their dividends for 25 consecutive years and meet certain size and liquidity requirements. Emmet calls it “the most solid investment in the world.”
He then revisits the pitch from recent Stock Club guest Porter Stansberry and makes the case for Altria Group Inc (MO). He finishes his list with Verizon (VZ), a wireless giant with a healthy moat and a 6%+ dividend. But it’s also staring down the looming threat of satellite internet providers.
Mike returns to familiar territory with Investor AB (STO: INVE-B), the “Swedish Berkshire Hathaway”, it's a holding company with stakes in public companies, medtech firms, and smaller private businesses. It’s a lovely way to snag a piece of the Swedish economy and is currently Mike’s largest position.
He then heads east with Tokio Marine (TYO: 8766), a Japanese insurance company riding the wave of the country’s stock market recovery. He shocks no one by pitching a stock that made last week’s portfolio as well: Waste Management (WM). At least this time, you get the reassurance that it’s also this month’s Stock of the Month.
We wrap up by checking in on Finance Minister Simon Harris’s recent comments about deemed disposal and the avenues available for investing in Ireland. With €170 billion sitting in Irish bank accounts, it’s clear that at least some of it could be put to work.
Psssst…. We don’t think you’ll want to miss this year’s Investicon. Grab your early bird tickets now: https://www.investicon.ie/
To celebrate our 300th episode, Stock of the Month is on sale for $149 for 2 years or $99 for one year. Grab your deal at https://www.mywallst.com/
Become a successful investor by checking out all the content MyWallSt has to offer:
📩 Email us: [email protected]
📚 Learn the fundamentals of investing by downloading our free Learn app: https://bit.ly/3DXPOz7
💻 Keep updated on stock market news by visiting our blog: https://mywallst.com/blog/
🎧 Tune in to our podcast Stock Club to stay updated on weekly news: https://mywallst.com/stock-investment-podcast/
🎉 Follow MyWallSt on social:
❌ X: @MyWallStHQ
💃 TikTok: @MyWallSt
📸 Instagram: @MyWallSt
🖥️ Facebook: @MyWallSt
👔 LinkedIn: MyWallSt
00:00 Intro
02:16 Dividend Stocks Setup
11:33 Why Dividends Stick
17:09 Modern Era Buybacks
21:34 Dividend Aristocrats ETF
25:46 Investor AB
29:45 Altria
34:33 Tokio Marine
37:58 Verizon
44:56 Waste Management
46:32 Irish Investing Law and Deemed Disposal